World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

World’s First Solid Tumor CAR-T Approved: Jiahui International Cancer Center Provides Access for Patients Worldwide

Cision PR Newswire by Cision PR Newswire
June 24, 2026
in Press Releases - Lifestyle
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

SHANGHAI, June 24, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) welcomes the approval of Satri-cel (CT041, Kaileimei®), the world’s first CAR-T cell therapy approved for the treatment of a solid tumor, marking a historic milestone in cancer care and opening new possibilities for patients from around the world.

Approved by China’s National Medical Products Administration (NMPA), Satri-cel is indicated for Claudin18.2-positive, HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in patients who have failed at least two prior lines of therapy.

As one of China’s leading destinations for advanced oncology care, Jiahui International Cancer Center is uniquely positioned to help eligible domestic and international patients access this breakthrough treatment through its multidisciplinary cancer program and dedicated international patient services.

In recent years, JICC has treated CAR-T patients from a diverse range of countries and regions, reflecting growing international interest in innovative cancer therapies available in China. The approval of the world’s first solid tumor CAR-T therapy is expected to further accelerate global demand for access to China’s rapidly evolving oncology innovations.

“Satri-cel’s approval is a landmark achievement for both patients and the global oncology community,” said Dr. Linli Xuan, Chief of Medical Oncology at Jiahui International Cancer Center. “For years, the successful application of CAR-T therapy in solid tumors has been one of cancer medicine’s most important challenges. This breakthrough not only offers new hope for patients with advanced gastric cancer, but also highlights China’s growing role in developing transformative cancer treatments. At Jiahui International Cancer Center, we are committed to helping patients from around the world access these innovations through expert multidisciplinary care, personalized treatment planning and dedicated international support services.”

JICC provides comprehensive oncology services spanning medical oncology, surgical oncology, radiation oncology, precision medicine and advanced cellular therapies. Through specialist consultations, multilingual coordination and streamlined care pathways, the center helps connect patients worldwide with the latest advances in cancer treatment.

Read the full story: https://www.jiahui.com/en/news/214

For international patient enquiries:

Email: internationaloffice@jiahui.com

WhatsApp: +852 4619 1904

Cision View original content:https://www.prnewswire.com/news-releases/worlds-first-solid-tumor-car-t-approved-jiahui-international-cancer-center-provides-access-for-patients-worldwide-302809054.html

SOURCE Jiahui Health

Cision PR Newswire

Cision PR Newswire

Related Posts

The One Where SHEGLAM Meets FRIENDS

October 26, 2026

Rapidus and HCLTech announce partnership for next-generation semiconductor technologies

October 26, 2026

Parloa’s Agent Management Platform now sold as an SAP Solution Extension for agentic customer interactions

October 26, 2026

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

October 26, 2026

SUNON Brings AI, Nature and Human-Centered Design to ORGATEC 2026

October 26, 2026

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

October 26, 2026

Popular News

  • Thunes Expands Real-Time Payouts to Bhutan, Unlocking the Nation’s Remittance Market

    0 shares
    Share 0 Tweet 0
  • Bloomberg Indices and HKEX Launch Co-branded Offshore RMB Bond Index Family to Support Growing Investor Demand in the Dim Sum Bond Market

    0 shares
    Share 0 Tweet 0
  • CANACCORD GENUITY GROUP INC. ANNOUNCES SALE OF ITS WEALTH MANAGEMENT BUSINESS IN THE UK & CROWN DEPENDENCIES TO CENTERBRIDGE PARTNERS, L.P. AND MUBADALA INVESTMENT COMPANY PJSC

    0 shares
    Share 0 Tweet 0
  • SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Portillo’s Inc. (NASDAQ: PTLO) — Investors Who Suffered Losses Are Encouraged to Contact the Firm.

    0 shares
    Share 0 Tweet 0
  • EFICYENT to Join Banks and Fintech Companies at Singapore FinTech Festival 2026

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler